https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/liver

The Latest

couple on the boardwalk surrounded by seagulls

This Week in HIV Research: When STIs Flock Together

July 18, 2019: Anal neoplasia risk amidst comorbid HPV and chlamydia; predictive modeling for PrEP outreach; long-term benefits of hepatitis C cure in coinfection; first-line therapy with dolutegravir/lamivudine.

Doctor is performing liver biopsy to women supporting with Ultrasound

Researchers Recommend Screening All People With HIV for Elevated Liver Function Values

Authors of a literature review note the high prevalence of liver disease among people with HIV and recommend a step-by-step approach to management.

This Week in HIV Research: Additional Nuance on Pregnancy and Antiretrovirals

Switching HIV treatment regimens during the first trimester; drivers of viral breakthrough during pregnancy; HIV’s effect on liver risk after hepatitis C treatment; hepatic steatosis among young people with HIV.

This Week in HIV Research: The Science of Risk

Traditional factors vs. HIV-specific factors in non-communicable complications; frailty and fracture risk among women; lipid measurements and coronary risks; new data on efavirenz and birth defects.

This Week in HIV Research: Rethinking PrEP Guidelines

Alternate PrEP guideline recommendations; partner notification and onward HIV transmission; shifting causes of death among HIV/HCV-coinfected people; correlates of lower adherence among people on methadone maintenance.

This Week in HIV Research: A New Frontier in Organ Transplantation

HIV-positive donor, HIV-negative recipient; continuum of care after incarceration in U.S.; reduced bone mineral density among men with HIV under 50; discouraging anti-inflammatory findings for an antiplatelet agent.

HCV Treatment in Advanced Liver Disease Img

HCV Treatment in Advanced Liver Disease

Despite being cured of hepatitis C, "patients with advanced liver disease may still be at considerable risk of [developing symptoms associated with cirrhosis] and liver cancer," according to researchers in the Target Consortium.

Looking Back at Liver Cancer Rates Among People Who Received Interferon Therapy Img

Looking Back at Liver Cancer Rates Among People Who Received Interferon Therapy

Researchers at the University of Toronto conducted an intensive review of 37 published studies in which interferon was used as treatment for HCV infection. Among participants who were cured, 3% subsequently developed liver cancer. Among participants ...

Barcelona: Reports of Unexpected Cases of Liver Cancer in People Undergoing Treatment With DAAs Img

Barcelona: Reports of Unexpected Cases of Liver Cancer in People Undergoing Treatment With DAAs

Doctors in Barcelona recently reported an unexpected increase in liver cancer recurrence in people who had been or who are being treated for chronic hepatitis C virus (HCV) infection with new potent all-oral medicines called direct acting antivirals ...

Bologna Researchers Find No Link Between DAAs and Liver Cancer Img

Bologna Researchers Find No Link Between DAAs and Liver Cancer

Spurred by reports from other cities, doctors in Bologna, Italy, have reviewed their database to assess possible risk factors for liver cancer development and recurrence in 344 participants who were treated for hepatitis C virus (HCV) infection with ...